CN114377068A - Traditional Chinese medicine preparation for treating nephrotic syndrome - Google Patents
Traditional Chinese medicine preparation for treating nephrotic syndrome Download PDFInfo
- Publication number
- CN114377068A CN114377068A CN202210234199.9A CN202210234199A CN114377068A CN 114377068 A CN114377068 A CN 114377068A CN 202210234199 A CN202210234199 A CN 202210234199A CN 114377068 A CN114377068 A CN 114377068A
- Authority
- CN
- China
- Prior art keywords
- parts
- nephrotic syndrome
- chinese medicine
- traditional chinese
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 27
- 206010029164 Nephrotic syndrome Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 claims abstract description 15
- 240000001519 Verbena officinalis Species 0.000 claims abstract description 15
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 claims abstract description 15
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 claims abstract description 15
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 241000220457 Crotalaria Species 0.000 claims abstract description 13
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 13
- 241001116757 Pyrrosia lingua Species 0.000 claims abstract description 13
- 235000002594 Solanum nigrum Nutrition 0.000 claims abstract description 13
- 240000002307 Solanum ptychanthum Species 0.000 claims abstract description 13
- 235000004338 Syringa vulgaris Nutrition 0.000 claims abstract description 13
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims abstract description 13
- 240000002239 Abelmoschus manihot var. tetraphyllus Species 0.000 claims abstract description 12
- 241000722953 Akebia Species 0.000 claims abstract description 12
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 11
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 11
- 240000000491 Corchorus aestuans Species 0.000 claims abstract description 10
- 235000011777 Corchorus aestuans Nutrition 0.000 claims abstract description 10
- 235000010862 Corchorus capsularis Nutrition 0.000 claims abstract description 10
- 241000208688 Eucommia Species 0.000 claims abstract description 10
- 244000104272 Bidens pilosa Species 0.000 claims abstract description 9
- 235000010662 Bidens pilosa Nutrition 0.000 claims abstract description 9
- 241000241550 Cyathula Species 0.000 claims abstract description 9
- 244000170916 Paeonia officinalis Species 0.000 claims abstract description 6
- 244000297179 Syringa vulgaris Species 0.000 claims abstract description 6
- 244000237330 gutta percha tree Species 0.000 claims abstract description 5
- 241000207925 Leonurus Species 0.000 claims description 12
- 241000245665 Taraxacum Species 0.000 claims description 12
- 240000004980 Rheum officinale Species 0.000 claims description 11
- 235000008081 Rheum officinale Nutrition 0.000 claims description 11
- 244000197975 Solidago virgaurea Species 0.000 claims description 8
- 235000000914 Solidago virgaurea Nutrition 0.000 claims description 8
- 241000222684 Grifola Species 0.000 claims description 7
- 244000171085 Polyporus umbellatus Species 0.000 claims description 5
- 235000004837 Polyporus umbellatus Nutrition 0.000 claims description 5
- 239000004480 active ingredient Substances 0.000 claims description 4
- 240000007284 Stenochlaena palustris Species 0.000 claims description 3
- 241000143476 Bidens Species 0.000 claims description 2
- 241000842328 Bidens bipinnata Species 0.000 claims description 2
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 2
- 244000000231 Sesamum indicum Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 17
- 230000001737 promoting effect Effects 0.000 abstract description 16
- 206010030113 Oedema Diseases 0.000 abstract description 15
- 208000004880 Polyuria Diseases 0.000 abstract description 13
- 230000017531 blood circulation Effects 0.000 abstract description 13
- 230000035619 diuresis Effects 0.000 abstract description 13
- 201000001474 proteinuria Diseases 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 6
- 231100000419 toxicity Toxicity 0.000 abstract description 6
- 230000001988 toxicity Effects 0.000 abstract description 6
- 206010018367 Glomerulonephritis chronic Diseases 0.000 abstract description 5
- 230000001939 inductive effect Effects 0.000 abstract description 5
- 206010037596 Pyelonephritis Diseases 0.000 abstract description 3
- 210000004404 adrenal cortex Anatomy 0.000 abstract description 3
- 230000001434 glomerular Effects 0.000 abstract description 3
- 229940088597 hormone Drugs 0.000 abstract description 3
- 239000005556 hormone Substances 0.000 abstract description 3
- 238000001727 in vivo Methods 0.000 abstract description 3
- 206010038464 renal hypertension Diseases 0.000 abstract description 3
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 240000007890 Leonurus cardiaca Species 0.000 abstract 1
- 241000222640 Polyporus Species 0.000 abstract 1
- 241001533947 Psammosilene Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 239000000463 material Substances 0.000 description 9
- 231100000331 toxic Toxicity 0.000 description 9
- 230000002588 toxic effect Effects 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 7
- 241000736199 Paeonia Species 0.000 description 7
- 241001104043 Syringa Species 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 206010017553 Furuncle Diseases 0.000 description 5
- 208000003623 Hypoalbuminemia Diseases 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 201000008383 nephritis Diseases 0.000 description 5
- 210000002700 urine Anatomy 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 102000004895 Lipoproteins Human genes 0.000 description 3
- 108090001030 Lipoproteins Proteins 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 230000024924 glomerular filtration Effects 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000270295 Serpentes Species 0.000 description 2
- 208000004078 Snake Bites Diseases 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 244000000053 intestinal parasite Species 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 201000003265 lymphadenitis Diseases 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 208000019206 urinary tract infection Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical class C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010007027 Calculus urinary Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 244000067456 Chrysanthemum coronarium Species 0.000 description 1
- 235000007871 Chrysanthemum coronarium Nutrition 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000022461 Glomerular disease Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 201000004331 Henoch-Schoenlein purpura Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 206010030111 Oedema mucosal Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000219061 Rheum Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 241000915604 Scutellaria barbata Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010049514 Traumatic fracture Diseases 0.000 description 1
- 241000052209 Triplasis Species 0.000 description 1
- 206010046274 Upper gastrointestinal haemorrhage Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000000240 adjuvant effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 206010002022 amyloidosis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 230000002016 colloidosmotic effect Effects 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000000585 glomerular basement membrane Anatomy 0.000 description 1
- 206010061989 glomerulosclerosis Diseases 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006575 hypertriglyceridemia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000024121 nodulation Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine preparation for treating nephrotic syndrome, which is prepared from dandelion, sculellaria barbata, black nightshade, akebia stem, lilac daphne flower bud, eucommia bark, pyrrosia lingua, garland jute seed, rhizoma alismatis, polyporus, peony, verbena, rhubarb, motherwort herb, medicinal cyathula root, psammosilene, sticktight, rust-coloured crotalaria herb and hibiscus root. The traditional Chinese medicine has the effects of clearing heat and removing toxicity, promoting blood circulation to remove blood stasis, and inducing diuresis to reduce edema. Can be used for treating chronic nephritis, pyelonephritis, nephrotic syndrome, etc., with good therapeutic effect and no major side effect. The traditional Chinese medicine preparation comprises the following raw material medicines: the eucommia ulmoides can reduce proteinuria, promote adrenal cortex function, improve hormone level in vivo, improve glomerular blood flow and the like, and has the effect of assisting in reducing renal hypertension.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine preparation for treating nephrotic syndrome.
Background
Nephrotic syndrome is a group of common clinical symptoms, and refers to a group of syndromes caused by various causes, mainly glomerulopathies such as increase of glomerular basement membrane permeability and concomitant decrease of glomerular filtration rate.
Nephrotic syndrome is typically characterized by "high three and low one", i.e., massive proteinuria, hypoalbuminemia, high grade edema, hyperlipidemia. By copious proteinuria is meant an increase in the permeability of the glomerular filtration membrane to plasma proteins resulting in an increase in the protein content of the urine when the molecular and charge barriers, and in particular the charge barrier, of the glomerular filtration membrane are compromised, and when the distal convoluted tubule resorption is exceeded, copious proteinuria is formed. Hypoalbuminemia refers to the loss of a large amount of albumin from urine, promoting the compensatory synthesis of albumin in the liver, and the insufficient increase in hepatic albumin synthesis to overcome the loss, and furthermore, hypo-eating, insufficient protein intake, malabsorption or loss due to gastrointestinal mucosal edema are also causes of hypoalbuminemia. High edema refers to hypoalbuminemia causing a decrease in plasma colloid osmotic pressure and the entry of water from the vascular lumen into the interstitial space. Hyperlipidemia refers to hypercholesterolemia or hypertriglyceridemia, increased concentrations of LDL, VLDL and lipoproteins in serum, often coexisting with hypoalbuminemia, whose mechanism of occurrence is associated with increased lipoprotein synthesis by the liver and decreased lipoprotein decomposition.
Nephrotic syndrome with complicated etiology, including chronic glomerulonephritis, nephrotic nephropathy of renal degeneration type, lipoid nephropathy, nephropathy in systemic lupus erythematosus, amyloidosis, multiple myeloma, glomerulosclerosis in diabetes, allergic purpura, renal venous thrombosis, etc., can cause nephrotic syndrome. The nephrotic syndrome is characterized by edema, oliguria, frequent infection history of upper respiratory tract infection, skin infection and the like before onset of disease, and accompanied symptoms of fatigue, anorexia, pallor, listlessness and the like, and serious patients have serous cavity hydrops and anuria.
The nephrotic syndrome has long attack time and is not easy to cure, great physical and psychological burden is brought to patients, the existing medical level has no obvious specific treatment scheme for treating the nephrotic syndrome, the existing treatment medicine has long treatment course, low cure rate and great side effect, and the pain of the patients is increased.
Disclosure of Invention
Aiming at the situations, in order to overcome the defects of the prior art, the invention aims to provide the traditional Chinese medicine preparation for treating nephrotic syndrome, which can effectively solve the problems of poor treatment effect and great side effect of nephrotic syndrome.
In order to achieve the purpose of the invention, the invention adopts the technical scheme that:
the traditional Chinese medicine preparation for treating nephrotic syndrome is characterized by comprising the following raw materials in parts by weight: 10-15 parts of dandelion, 11-15 parts of sculellaria barbata, 8-12 parts of black nightshade, 4-8 parts of akebia stem, 8-12 parts of lilac daphne flower bud, 8-13 parts of eucommia ulmoides, 6-11 parts of pyrrosia lingua, 9-11 parts of garland sesame seed, 5-10 parts of rhizoma alismatis, 6-12 parts of grifola, 4-9 parts of peony, 5-11 parts of verbena, 3-6 parts of rheum officinale, 10-12 parts of leonurus, 6-9 parts of medicinal cyathula root, 9-15 parts of psammophyte goldenrod herb, 8-15 parts of bidens bipinnata, 10-18 parts of rust-coloured crotalaria herb and 12-18 parts of hibiscus root.
The preferable weight ratio of each active component is as follows: 10 parts of dandelion, 11 parts of sculellaria barbata, 8 parts of black nightshade, 4 parts of akebia stem, 8 parts of lilac daphne flower bud, 8 parts of eucommia bark, 6 parts of pyrrosia lingua, 9 parts of garland jute seed, 5 parts of rhizoma alismatis, 6 parts of grifola, 4 parts of Chinese herbaceous peony, 5 parts of verbena, 3 parts of rheum officinale, 10 parts of motherwort, 6 parts of medicinal cyathula root, 9 parts of goldenrod, 8 parts of sticktight, 10 parts of rust-coloured crotalaria herb and 12 parts of hibiscus root.
The preferable weight ratio of each active component is as follows: 13 parts of dandelion, 14 parts of sculellaria barbata, 10 parts of black nightshade, 5 parts of akebia stem, 10 parts of lilac daphne flower bud, 11 parts of eucommia bark, 9 parts of pyrrosia lingua, 10 parts of garland jute seed, 8 parts of rhizoma alismatis, 9 parts of polyporus umbellatus, 7 parts of Chinese herbaceous peony, 9 parts of verbena, 4 parts of rheum officinale, 11 parts of motherwort, 8 parts of medicinal cyathula root, 12 parts of goldenrod, 13 parts of sticktight, 14 parts of rust-coloured crotalaria herb and 15 parts of hibiscus root.
The preferable weight ratio of each active component is as follows: 15 parts of dandelion, 15 parts of sculellaria barbata, 12 parts of black nightshade, 8 parts of akebia stem, 12 parts of lilac daphne flower bud, 13 parts of eucommia bark, 11 parts of pyrrosia lingua, 11 parts of garland jute seed, 10 parts of rhizoma alismatis, 12 parts of grifola, 9 parts of Chinese herbaceous peony, 11 parts of verbena, 6 parts of rheum officinale, 12 parts of motherwort, 9 parts of medicinal cyathula root, 15 parts of climbing fern, 15 parts of bidens pilosula, 18 parts of rust-coloured crotalaria herb and 18 parts of hibiscus root.
The traditional Chinese medicine is a tablet, and various raw materials are cleaned, dried, disinfected, powdered and mixed to prepare the tablet according to a conventional method.
The usage and dosage are as follows: it is taken with warm water, three times a day, 3 tablets each time, after meal.
The medicinal properties of the active ingredients adopted by the invention are as follows:
dandelion: clear heat and remove toxicity, induce diuresis and dissipate nodulation. It can be used for treating acute mastitis, lymphadenitis, lymphoid tuberculosis, furunculosis, acute conjunctivitis, common cold with fever, acute tonsillitis, acute bronchitis, gastritis, hepatitis, cholecystitis, and urinary tract infection.
Barbed skullcap herb: clearing away heat and toxic material, promoting blood circulation, dispelling blood stasis, and promoting urination. Belongs to heat-clearing and toxicity-removing herbs in the category of heat-clearing herbs. Can be used for treating chronic nephritis and edema.
Black nightshade: clearing away heat and toxic material, promoting blood circulation and eliminating swelling. It can be used for treating furuncle, carbuncle, erysipelas, traumatic injury, sprain, chronic tracheitis, and acute nephritis.
B, wood through: clear heart fire, induce diuresis, dredge meridians and promote lactation. Belongs to the diuresis and stranguria treatment drugs classified under the diuresis and dampness eliminating drugs. Has diuretic and antibacterial effects.
Lilac daphne flower bud: it has the actions of inducing diuresis to alleviate edema, promoting blood circulation to stop pain, clearing away heat and toxic material.
Eucommia ulmoides: has effects in tonifying liver and kidney, strengthening muscle and bone, regulating Chong and ren meridians, and preventing miscarriage. Can reduce proteinuria, promote adrenal cortex function, increase in vivo hormone level, and improve glomerular blood flow. It also has adjuvant effect on renal hypertension.
And (3) pyrrosia lingua: it has effects in promoting urination, relieving stranguria, clearing lung-heat, relieving cough, cooling blood, and stopping bleeding, and can be used for treating stranguria, hematuria, lithangiuria, nephritis, metrorrhagia, dysentery, cough due to lung heat, chronic tracheitis, and incised wound.
And (3) crowndaisy hemp seed: clear heat and cool blood, activate blood, remove toxicity and promote eruption. The natural alkannin compounds and their derivatives in radix Arnebiae have cytotoxic effect and anti-tumor effect of different degrees.
Rhizoma alismatis: has effects in cooling blood, dredging channels, clearing away heat and toxic materials, relieving itching, expelling intestinal parasites, and relieving flatulence. And has effects of promoting blood circulation for removing blood stasis, and relieving cough.
And (3) polyporus umbellatus: induce diuresis to alleviate edema, clear heat and remove toxicity. Can be used for treating abdominal edema, edema of face and foot, carbuncle, furuncle, and snake and insect bite; ascites due to late schistosomiasis.
Peony: has effects of dispersing stagnated liver qi, promoting blood circulation, relieving pain, relieving restlessness, and promoting urination.
Verbena: has effects in cooling blood, dredging channels, clearing away heat and toxic materials, relieving itching, expelling intestinal parasites, and relieving flatulence. And has effects of promoting blood circulation for removing blood stasis, and relieving cough. The verbena is a special traditional Chinese medicine capable of preventing cancers, can effectively prevent canceration of cells, can also inhibit regeneration of cancer cells, and obviously reduces the incidence rate of the cancers. In addition, verbena is a common drug for treating cancer, and can relieve the symptoms of cancer patients.
Rhubarb: purge heat and unblock intestines, cool blood and remove toxicity, dispel stasis and dredge meridians. For: constipation due to damp-heat, abdominal pain due to stagnation, dysentery with difficulty, jaundice due to damp-heat, hematemesis, epistaxis, conjunctival congestion, pharyngeal swelling, abdominal pain due to intestinal abscess, carbuncle, furuncle, amenorrhea due to blood stasis, traumatic injury, and external treatment for scald due to water and fire; upper gastrointestinal hemorrhage.
Motherwort: promoting blood circulation to regulate menstruation, inducing diuresis to alleviate edema, clearing away heat and toxic materials.
Radix cyathulae: radix Cyathulae has effects of promoting blood circulation, dredging channels, dispelling pathogenic wind, removing dampness, promoting joint movement, and inducing diuresis for treating stranguria.
And (3) golden sand grass: clearing away heat; removing dampness; relaxing tendons and activating collaterals; stopping bleeding. Major urinary tract infection; urinary calculus; edema due to nephritis; hepatitis; dysentery; conjunctival congestion with swelling and pain; rheumatic arthralgia; numbness of the bones and muscles; traumatic fractures; bleeding due to trauma.
Bidens pilosa L: clearing away heat, removing toxic material, dissipating blood stasis and relieving swelling. It can be used for treating malaria, diarrhea, dysentery, hepatitis, acute nephritis, gastralgia, dysphagia, acute appendicitis, laryngopharynx swelling and pain, traumatic injury, and snake and insect bite.
Rust-colored crotalaria herb: nourishing kidney and liver, relieving cough and asthma, promoting diuresis and removing toxic substance. Yunnan Chinese herbal medicine: "diminish inflammation, induce diuresis". Can be used for treating dysuria, whitish and turbid urine, nephritis, lymphadenitis, parotitis, tonsillitis, chronic bronchitis, and asthma. "south medicine" Chinese herbal medicine: the main treatment is as follows: deficiency of liver and kidney, tinnitus, deafness, dizziness, blurred vision; menorrhagia; cough and asthma, chronic bronchitis; chronic nephritis, cystitis; furuncle. "
Lotus root: clearing away heat and toxic materials; cool blood and relieve swelling. Beginning of superficial infection with pyogenic infections; ecthyma; conjunctival congestion with swelling and pain; pulmonary abscess; cough and asthma; dysentery with reddish white feces; leucorrhea of women; pyelonephritis.
The traditional Chinese medicine has the effects of clearing heat and removing toxicity, promoting blood circulation to remove blood stasis, and inducing diuresis to reduce edema. Can be used for treating chronic nephritis, pyelonephritis, nephrotic syndrome, etc., with good therapeutic effect and no major side effect. The traditional Chinese medicine preparation comprises the following raw material medicines: the eucommia ulmoides can reduce proteinuria, promote adrenal cortex function, improve hormone level in vivo, improve glomerular blood flow and the like, has the effect of assisting reduction of renal hypertension, and has a good treatment effect on the nephrotic syndrome.
Detailed Description
In order to make the content of the present invention more clearly understood, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention. Wherein like parts are designated by like reference numerals. It should be noted that the terms "front," "back," "left," "right," "upper" and "lower" used in the following description refer to directions, and the terms "inner" and "outer" refer to directions toward and away from, respectively, the geometric center of a particular component.
Example 1:
taking 10 parts of dandelion, 11 parts of sculellaria barbata, 8 parts of black nightshade, 4 parts of akebia stem, 8 parts of lilac daphne flower bud, 8 parts of eucommia bark, 6 parts of pyrrosia lingua, 9 parts of garland jute seed, 5 parts of rhizoma alismatis, 6 parts of polyporus umbellatus, 4 parts of Chinese herbaceous peony, 5 parts of verbena, 3 parts of rheum officinale, 10 parts of motherwort, 6 parts of radix cyathulae, 9 parts of goldenrod, 8 parts of sticktight, 10 parts of rust-coloured crotalaria herb and 12 parts of hibiscus root, cleaning the raw materials, drying, sterilizing, grinding and mixing, preparing the raw materials into tablets according to a conventional method, and taking the tablets in a fixed amount.
The usage and dosage are as follows: it is taken with warm water, three times a day, 3 tablets each time, after meal.
Example 2:
taking 13 parts of dandelion, 14 parts of sculellaria barbata, 10 parts of black nightshade, 5 parts of akebia stem, 10 parts of lilac daphne flower bud, 11 parts of eucommia bark, 9 parts of pyrrosia lingua, 10 parts of garland jute seed, 8 parts of rhizoma alismatis, 9 parts of polyporus umbellatus, 7 parts of Chinese herbaceous peony, 9 parts of verbena, 4 parts of rheum officinale, 11 parts of motherwort, 8 parts of radix cyathulae, 12 parts of goldenrod, 13 parts of sticktight, 14 parts of rust-coloured crotalaria herb and 15 parts of hibiscus root, cleaning the raw materials, drying, sterilizing, grinding and mixing, preparing the raw materials into tablets according to a conventional method, and taking the tablets in a fixed amount.
The usage and dosage are as follows: it is taken with warm water, three times a day, 3 tablets each time, after meal.
Example 3:
taking 15 parts of dandelion, 15 parts of sculellaria barbata, 12 parts of black nightshade, 8 parts of akebia stem, 12 parts of lilac daphne flower bud, 13 parts of eucommia bark, 11 parts of pyrrosia lingua, 11 parts of garland jute seed, 10 parts of rhizoma alismatis, 12 parts of grifola, 9 parts of Chinese herbaceous peony, 11 parts of verbena, 6 parts of rheum officinale, 12 parts of motherwort, 9 parts of radix cyathulae, 15 parts of climbing fern, 15 parts of sticktight, 18 parts of rust-coloured crotalaria herb, and 18 parts of hibiscus root, cleaning the raw materials, drying, sterilizing, grinding and mixing, preparing the raw materials into tablets according to a conventional method, and taking the tablets in a fixed amount.
The usage and dosage are as follows: it is taken with warm water, three times a day, 3 tablets each time, after meal.
The treatment method comprises the following steps:
the preparation is taken with warm water, three times a day, 3 tablets each time, and the treatment time is calculated according to the patient's condition, the preparation is taken by patients with mild diseases for about 3 months, and the preparation is taken by patients with severe diseases for more than 12 months.
Treatment effect judgment standard:
and (3) complete alleviation: less than 0.3 g/day of urine protein, 3 consecutive days, edema, blood lipid, nephrotic syndrome sign are completely eliminated, the plasma albumin is more than 35 g/day, and the renal function is normal.
Partial mitigation: 0.31-2.0 g/day of urine protein, 3 consecutive days, nephrotic syndrome is completely eliminated, and renal function is improved.
And (4) invalidation: the urinary protein is more than 2.0 g/day, the sign of nephrotic syndrome is not eliminated, and the renal function is not improved.
The traditional Chinese medicine preparation has good absorption effect and obvious curative effect, is beneficial to timely alleviating symptoms of patients, can clear away heat and toxic materials, induce diuresis to reduce edema, reduce proteinuria and blood fat and blood sugar through various raw material medicines in the traditional Chinese medicine preparation, and can effectively treat nephrotic syndrome.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention, and any modifications, equivalents and improvements made within the spirit and principle of the present invention should be included in the scope of the present invention.
Claims (5)
1. The traditional Chinese medicine preparation for treating nephrotic syndrome is characterized by comprising the following raw materials in parts by weight: 10-15 parts of dandelion, 11-15 parts of sculellaria barbata, 8-12 parts of black nightshade, 4-8 parts of akebia stem, 8-12 parts of lilac daphne flower bud, 8-13 parts of eucommia ulmoides, 6-11 parts of pyrrosia lingua, 9-11 parts of garland sesame seed, 5-10 parts of rhizoma alismatis, 6-12 parts of grifola, 4-9 parts of peony, 5-11 parts of verbena, 3-6 parts of rheum officinale, 10-12 parts of leonurus, 6-9 parts of medicinal cyathula root, 9-15 parts of psammophyte goldenrod herb, 8-15 parts of bidens bipinnata, 10-18 parts of rust-coloured crotalaria herb and 12-18 parts of hibiscus root.
2. The traditional Chinese medicine preparation for treating nephrotic syndrome according to claim 1, characterized in that the active ingredients comprise the following raw materials in parts by weight: 10 parts of dandelion, 11 parts of sculellaria barbata, 8 parts of black nightshade, 4 parts of akebia stem, 8 parts of lilac daphne flower bud, 8 parts of eucommia bark, 6 parts of pyrrosia lingua, 9 parts of garland jute seed, 5 parts of rhizoma alismatis, 6 parts of grifola, 4 parts of Chinese herbaceous peony, 5 parts of verbena, 3 parts of rheum officinale, 10 parts of motherwort, 6 parts of medicinal cyathula root, 9 parts of goldenrod, 8 parts of sticktight, 10 parts of rust-coloured crotalaria herb and 12 parts of hibiscus root.
3. The traditional Chinese medicine preparation for treating nephrotic syndrome according to claim 1, characterized in that the active ingredients comprise the following raw materials in parts by weight: 13 parts of dandelion, 14 parts of sculellaria barbata, 10 parts of black nightshade, 5 parts of akebia stem, 10 parts of lilac daphne flower bud, 11 parts of eucommia bark, 9 parts of pyrrosia lingua, 10 parts of garland jute seed, 8 parts of rhizoma alismatis, 9 parts of polyporus umbellatus, 7 parts of Chinese herbaceous peony, 9 parts of verbena, 4 parts of rheum officinale, 11 parts of motherwort, 8 parts of medicinal cyathula root, 12 parts of goldenrod, 13 parts of sticktight, 14 parts of rust-coloured crotalaria herb and 15 parts of hibiscus root.
4. The traditional Chinese medicine preparation for treating nephrotic syndrome according to claim 1, characterized in that the active ingredients comprise the following raw materials in parts by weight: 15 parts of dandelion, 15 parts of sculellaria barbata, 12 parts of black nightshade, 8 parts of akebia stem, 12 parts of lilac daphne flower bud, 13 parts of eucommia bark, 11 parts of pyrrosia lingua, 11 parts of garland jute seed, 10 parts of rhizoma alismatis, 12 parts of grifola, 9 parts of Chinese herbaceous peony, 11 parts of verbena, 6 parts of rheum officinale, 12 parts of motherwort, 9 parts of medicinal cyathula root, 15 parts of climbing fern, 15 parts of bidens pilosula, 18 parts of rust-coloured crotalaria herb and 18 parts of hibiscus root.
5. The Chinese medicinal preparation for treating nephrotic syndrome according to any one of claims 1 to 4, wherein the Chinese medicament is a tablet.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210234199.9A CN114377068A (en) | 2022-03-10 | 2022-03-10 | Traditional Chinese medicine preparation for treating nephrotic syndrome |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210234199.9A CN114377068A (en) | 2022-03-10 | 2022-03-10 | Traditional Chinese medicine preparation for treating nephrotic syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114377068A true CN114377068A (en) | 2022-04-22 |
Family
ID=81206232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210234199.9A Pending CN114377068A (en) | 2022-03-10 | 2022-03-10 | Traditional Chinese medicine preparation for treating nephrotic syndrome |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114377068A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229292A (en) * | 2008-01-10 | 2008-07-30 | 程立国 | Chinese traditional medicine preparation for treating nephropathy, preparation method and applications thereof |
CN103393851A (en) * | 2013-08-10 | 2013-11-20 | 常玲玲 | Chinese medicinal preparation for treating nephrotic syndrome and preparation method |
-
2022
- 2022-03-10 CN CN202210234199.9A patent/CN114377068A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229292A (en) * | 2008-01-10 | 2008-07-30 | 程立国 | Chinese traditional medicine preparation for treating nephropathy, preparation method and applications thereof |
CN103393851A (en) * | 2013-08-10 | 2013-11-20 | 常玲玲 | Chinese medicinal preparation for treating nephrotic syndrome and preparation method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101934025B (en) | Traditional Chinese medicine for clearing away heat and toxic material | |
CN102139024A (en) | Traditional Chinese medicine for treating bovine mastitis | |
CN104906066A (en) | Lincomycin hydrochloride compound vaginal effervescent tablets and preparation method thereof | |
CN1876053A (en) | A pharmaceutical used for moxibustion and preparation method thereof | |
CN1709336A (en) | Infrared nasitis plaster and its preparing method | |
CN101856481A (en) | Externally used ointment for dispersing swelling and dissipating binds | |
CN102764360B (en) | Traditional Chinese medicine composition for treating acute cystitis | |
CN104547936A (en) | Traditional Chinese medicine for treating local induration of vascular access of hemodialysis patient | |
CN114377068A (en) | Traditional Chinese medicine preparation for treating nephrotic syndrome | |
CN106074917A (en) | A kind of Chinese medicine treating renal calculus and preparation method thereof | |
CN112972557A (en) | Medicinal liquor for treating arthralgia and myalgia and preparation method thereof | |
CN1223132A (en) | Medicine for curing dermatosis | |
CN112316034A (en) | Externally-applied traditional Chinese medicine composition for treating chronic pharyngitis as well as preparation method and application thereof | |
CN105213870A (en) | A kind of Chinese medicine composition for the treatment of chronic bronchitis | |
CN105056026A (en) | External ointment for treating pyogenic paronychia | |
CN105031595A (en) | Traditional Chinese medicine tablet for treating nummular eczema and preparing method thereof | |
CN102908427B (en) | Externally applied traditional Chinese medicine for treating trichomonas vaginitis | |
CN104474153A (en) | Medicine used for diminishing inflammation, relieving pain,eliminating blood stasis and promoting tissue regeneration | |
CN103933429A (en) | Traditional Chinese medicine composition for treating vaginitis | |
CN102940806B (en) | Chinese medicinal composition for treating hyperlipidemia | |
CN107551030B (en) | A kind of Chinese medicine composition, preparation and the preparation method of anti-venous thronbosis | |
CN105362436A (en) | Traditional Chinese medicine composition with efficacies of invigorating circulation of blood and eliminating pus | |
CN105232886A (en) | Sanlong Deida wine and preparation method | |
CN104815293A (en) | Traditional Chinese medicine tablet for treating otitis media and preparation method thereof | |
CN103349720A (en) | Traditional Chinese medicine composition for treating acute cystitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220422 |